젖소 유방염 시장 : 제품 유형, 투여 방법, 동물 유형, 최종사용자별 - 세계 예측(2025-2030년)

The Bovine Mastitis Market was valued at USD 1.41 billion in 2023, expected to reach USD 1.48 billion in 2024, and is projected to grow at a CAGR of 5.72%, to USD 2.08 billion by 2030.

Bovine Mastitis refers to the inflammation of the mammary gland in dairy cattle, primarily caused by bacterial infection. This condition significantly impacts dairy production, reducing milk yield and quality, and increasing veterinary costs, thus necessitating effective management strategies. Addressing bovine mastitis involves applications in pharmaceuticals, diagnostics, and automated milking systems designed to prevent, detect, and treat infections. The end-use scope primarily encompasses dairy farms, veterinary clinics, and research institutes. Key growth influencers include the increasing demand for dairy products, advancements in veterinary healthcare, and the shift towards sustainable and organic farming practices. Innovations in diagnostic technologies, such as biosensors and molecular assays, provide lucrative opportunities. These innovations enable early and accurate detection, promoting improved herd health management and higher milk production efficiency. Ongoing development in automated milking machinery and data analytics tools also offers significant potential to revolutionize herd management practices by continuously monitoring animal health.

However, market growth is challenged by factors like antibiotic resistance, regulatory concerns over treatment residues in milk, and the high cost of advanced diagnostic solutions. Additionally, inconsistent disease management practices across different regions hinder the uniform application of solutions. Investment in new antibiotics and alternative therapies such as probiotics and vaccines is crucial, notwithstanding the necessity for stringent regulatory adherence. Research in genetic markers for mastitis resistance and enhancing the efficacy of existing treatments remains a key area for innovation. Collaborating with academic institutions and leveraging advanced technologies like AI for predictive analytics in herd health management can further drive growth. The nature of the bovine mastitis market is highly competitive, with increasing emphasis on sustainable practices and technological advances. Businesses must focus on providing cost-effective, regulatory-compliant solutions while fostering partnerships with livestock associations and leveraging digital platforms for broader market penetration.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bovine Mastitis Market

The Bovine Mastitis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidences of antimicrobial resistance in bovine mastitis pathogens necessitating novel therapeutic approaches
  • Enhanced governmental and non-governmental initiatives promoting bovine health and mastitis prevention
  • Financial incentives and subsidies encouraging the adoption of mastitis control programs in dairy farms
• Market Restraints
  • High cost of advanced treatment and diagnostic solutions
• Market Opportunities
  • Developing eco-friendly and sustainable gaming keyboards for environmentally conscious gamers
  • Creating customizable gaming keyboards with advanced RGB lighting and mechanical switch options
• Market Challenges
  • Supply chain disruptions impacting manufacturing and timely delivery of gaming keyboards

Porter's Five Forces: A Strategic Tool for Navigating the Bovine Mastitis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bovine Mastitis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bovine Mastitis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bovine Mastitis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bovine Mastitis Market

A detailed market share analysis in the Bovine Mastitis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bovine Mastitis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bovine Mastitis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bovine Mastitis Market

A strategic analysis of the Bovine Mastitis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bovine Mastitis Market, highlighting leading vendors and their innovative profiles. These include Advanced Animal Diagnostics, Inc., AgriLabs, Boehringer Ingelheim GmbH, Ceva Sante Animale, CHARM Sciences, Inc., Elanco Animal Health Incorporated, HIPRA, Huvepharma AD, IDEXX Laboratories, Inc., ImmuCell Corporation, Mastaplex Limited, Merck & Co., Inc., MSD Animal Health, Nanion Technologies GmbH, Neogen Corporation, Phibro Animal Health Corporation, Thermo Fisher Scientific Inc., Virbac S.A., Westway Health, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Bovine Mastitis Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Anti-Inflammatory, Antibiotics, and Pain Relievers.
• Based on Mode Of Administration, market is studied across Intramammary and Systemic. The Intramammary is further studied across Liquid and Ointment. The Liquid is further studied across Multiple Dose and Single Dose. The Systemic is further studied across Injectable and Oral. The Oral is further studied across Capsules and Tablets.
• Based on Animal Type, market is studied across Buffaloes and Cows. The Cows is further studied across Beef Cows and Dairy Cows.
• Based on End User, market is studied across Research Institutes, Veterinary Clinics, and Veterinary Hospitals. The Veterinary Clinics is further studied across Private. The Veterinary Hospitals is further studied across Public.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidences of antimicrobial resistance in bovine mastitis pathogens necessitating novel therapeutic approaches
    • 5.1.1.2. Enhanced governmental and non-governmental initiatives promoting bovine health and mastitis prevention
    • 5.1.1.3. Financial incentives and subsidies encouraging the adoption of mastitis control programs in dairy farms
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of advanced treatment and diagnostic solutions
  • 5.1.3. Opportunities
    • 5.1.3.1. Developing eco-friendly and sustainable gaming keyboards for environmentally conscious gamers
    • 5.1.3.2. Creating customizable gaming keyboards with advanced RGB lighting and mechanical switch options
  • 5.1.4. Challenges
    • 5.1.4.1. Supply chain disruptions impacting manufacturing and timely delivery of gaming keyboards
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bovine Mastitis Market, by Product Type

• 6.1. Introduction
• 6.2. Anti-Inflammatory
• 6.3. Antibiotics
• 6.4. Pain Relievers

7. Bovine Mastitis Market, by Mode Of Administration

• 7.1. Introduction
• 7.2. Intramammary
  • 7.2.1. Liquid
    • 7.2.1.1. Multiple Dose
    • 7.2.1.2. Single Dose
  • 7.2.2. Ointment
• 7.3. Systemic
  • 7.3.1. Injectable
  • 7.3.2. Oral
    • 7.3.2.1. Capsules
    • 7.3.2.2. Tablets

8. Bovine Mastitis Market, by Animal Type

• 8.1. Introduction
• 8.2. Buffaloes
• 8.3. Cows
  • 8.3.1. Beef Cows
  • 8.3.2. Dairy Cows

9. Bovine Mastitis Market, by End User

• 9.1. Introduction
• 9.2. Research Institutes
• 9.3. Veterinary Clinics
  • 9.3.1. Private
• 9.4. Veterinary Hospitals
  • 9.4.1. Public

10. Americas Bovine Mastitis Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Bovine Mastitis Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Bovine Mastitis Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advanced Animal Diagnostics, Inc.
• 2. AgriLabs
• 3. Boehringer Ingelheim GmbH
• 4. Ceva Sante Animale
• 5. CHARM Sciences, Inc.
• 6. Elanco Animal Health Incorporated
• 7. HIPRA
• 8. Huvepharma AD
• 9. IDEXX Laboratories, Inc.
• 10. ImmuCell Corporation
• 11. Mastaplex Limited
• 12. Merck & Co., Inc.
• 13. MSD Animal Health
• 14. Nanion Technologies GmbH
• 15. Neogen Corporation
• 16. Phibro Animal Health Corporation
• 17. Thermo Fisher Scientific Inc.
• 18. Virbac S.A.
• 19. Westway Health
• 20. Zoetis Inc.